Correction: Real-World Outcomes of Sequential Afatinib and Osimertinib Versus Afatinib and Chemotherapy in EGFR-Mutant NSCLC: Taiwan Multicenter GIANT Study.
Journal
Targeted oncology
ISSN
1776-260X
Date Issued
2026-04-30
Author(s)
Ko, How-Wen
Liao, Ying-Ting
Huang, Yen-Hsiang
Lin, Yu-Ching
Liu, Ping-Chi
Wang, Chin-Chou
Tsai, Jeng-Shiuan
Chen, Yuh-Min
Yang, Tsung-Ying
Yang, Cheng-Ta
Type
corrigendum